| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $770K | -89.3% |
| SG&A Expense | $5.0M | -13.2% |
| Operating Income | -$5.7M | +55.5% |
| Net Income | -$5.6M | +55.5% |
| EPS (Basic) | -$5.79 | -50.8% |
| EPS (Diluted) | -$5.79 | -50.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -58.7% |
| Current Assets | $3.0M | -54.2% |
| Total Assets | $3.0M | -54.1% |
| Total Liabilities | $1.5M | +16.3% |
| Stockholders' Equity | $1.5M | -71.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.5M | +64.8% |
| Financing Cash Flow | $1.1M | -84.0% |